Uso Della Polichemioterapia Nel Carcinoma Prostatico in Fase Avanzata,Ormono-Resistente

Chlebowsky R. T. : Cyclophosphamide versus the combination of adriamycin, 5-fluorouracil and cyclophosphamide in the treatment of metastatic prostatic cancer: a randomized trial. Cancer, 42; 2546 (1978).

Collier D. , Soloway M. S. : Doxorubicin hydrochloride, cyclophosphamide, and 5-fluorouracil combination in advanced prostate and transitional cell carcinoma. Urology, 8; 459 (1976).

Dewys W. D. , Bauer M. , Colsky J. , Cooper R. A. , Creech R. , Carbone P. P. : Comparative trial of adriamycin and 5-fluorouracil in advanced prostatic cancer: Progress report. Cancer Chemother. Rep., 61; 325–328 (1977).

Ihde D. G. : Combination chemotherapy in metastatic carcinoma of the prostate: method of detecting tumor response and progression, 19; 339 (1978).

Ihde D. C. : Effective treatment of hormonally-unresponsive metastatic carcinoma of the prostate with adriamycin and cyclophosphamide. Cancer, 45; 1300 (1980).

Isaacs J. T. : Animal models of hormone sensitive and insensitive prostatic adenocarcinoma: Dunning R-3327-H, R 3327-HI and 3-3327-AT. Cancer Res., 38; 4353 (1978).

Izbecki R. , Amer M. , Ai-Sarraf M. : A prospective study of a combination of adriamycin and Cytoxan in the treatment of patients with advanced prostatic cancer. Proc. Amer. Ass. Cancer Res. Amer. Soc. Clin. Oncol., 19; 312 (1978).

Kane R. D. , Stocks L.H. , Paulson D. F. : Multiple drug chemotherapy regimen for patients with hormonally-unresponsive carcinoma of the prostate: a preliminary report. J. Urol., 117; 467 (1977).

Merrin C. : Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin. J. Urol., 115; 86 (1976).

Murphy G. P. : Management of disseminated prostatic carcinoma. In: Murphy G. P. (ed.): Prostatic Cancer, p. 213. Littleton, MA: PSG Publ. Co. Inc., 1979.

Rosso R. , Guarneri D. : Chemotherapy of prostatic cancer. Proc. Intern. Symposium on the management of prostatic carcinoma (1982).

Schmidt J. D. : Chemotherapy of advanced prostatic cancer: evaluation of response parameters. Urology, 7; 602 (1976).

Scott W. W. , Gibbons R. P. , Johnson D. E. , Prout G. R. , Schmidt J. D. , Chu T. M. , Gaeta J. F. , Joiner J. , Saroff Murphy G. P. : Comparison of 5-fluorouracil and cyclophophamide in patients with advanced carcinoma of the prostate. Cancer Chemother. Rep., 59; 195 (1975).

Torti F. M. , Carter S. K. : The chemotherapy of prostatic adenocarcinoma. Ann. Intern. Med., 92; 681–689 (1980).

Yagoda A. : Non-hormonal cytotoxic agents in the treatment of prostatic adenocarcinoma. Cancer, 32; 1131 (1973).

Yagoda A. : Chemotherapy of renal, urothelial tract, and prostatic cancer. In: Greenspan E. M. (ed.): Clinical Interpretation and Practice of Cancer Chemotherapy, New York 1982.